BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6126123)

  • 1. Central control of peripheral circulating somatostatin in dogs: effect of 2-deoxyglucose.
    Ipp E; Piran U; Richter H; Garberoglio C; Moossa A; Rubenstein AH
    Am J Physiol; 1982 Sep; 243(3):E213-6. PubMed ID: 6126123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
    Wasada T; Dobbs RE; Harris V; Unger RH
    Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system-mediated stimulation of glucagon secretion in the dog following 2-deoxyglucose.
    Frohman LA; Nagai K
    Metabolism; 1976 Nov; 25(11 Suppl 1):1449-52. PubMed ID: 790091
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of insulin, glucose, and 2-deoxy-glucose infusion into the third cerebral ventricle of conscious dogs on plasma insulin, glucose, and free fatty acids.
    Taborsky GJ; Bergman RN
    Diabetes; 1980 Apr; 29(4):278-83. PubMed ID: 6987116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intracellular glucopenia on pulsatile growth hormone secretion: mediation in part by somatostatin.
    Painson JC; Tannenbaum GS
    Endocrinology; 1985 Sep; 117(3):1132-8. PubMed ID: 2862015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraventricular 2-deoxyglucose, glucose, insulin, and free fatty acid mobilization.
    Coimbra CC; Gross JL; Migliorini RH
    Am J Physiol; 1979 Apr; 236(4):E317-27. PubMed ID: 434193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of somatostatin on glucose homeostasis in conscious long-fasted dogs.
    Stevenson RW; Steiner KE; Hendrick GK; Cherrington AD
    Am J Physiol; 1987 Oct; 253(4 Pt 1):E435-42. PubMed ID: 2889363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic effect of 2-deoxy-D-glucose on plasma glucagon levels in conscious rats.
    Haito K; Takeda A; Kagawa S; Shimizu S; Matsuoka A
    Horm Metab Res; 1984 Dec; 16 Suppl 1():110-3. PubMed ID: 6398250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased thirst and plasma arginine vasopressin levels during 2-deoxy-D-glucose-induced glucoprivation in humans.
    Thompson DA; Campbell RG; Lilavivat U; Welle SL; Robertson GL
    J Clin Invest; 1981 Apr; 67(4):1083-93. PubMed ID: 7204569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of pancreatic polypeptide and glucagon secretion by 2-deoxy-D-glucose in man: evidence for cholinergic mediation.
    Hedo JA; Villanueva ML; Marco J
    J Clin Endocrinol Metab; 1978 Aug; 47(2):366-71. PubMed ID: 400718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of the effect of oxytocin on plasma concentrations of glucose, insulin and glucagon in conscious dogs.
    Vilhardt H; Krarup T; Holst JJ; Bie P
    J Endocrinol; 1986 Feb; 108(2):293-8. PubMed ID: 2869096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma glucose, insulin and cardiovascular responses after intravenous intracerebroventricular injections of insulin, 2-deoxyglucose and glucose in rats.
    Schultz-Klarr S; Wright-Richey J; Dunbar JC
    Diabetes Res Clin Pract; 1994 Dec; 26(2):81-9. PubMed ID: 7705198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing actions of glucagon and insulin on splanchnic d cell function.
    Kawai K; Unger RH
    J Clin Invest; 1983 Mar; 71(3):721-5. PubMed ID: 6131079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon.
    Shulman GI; Liljenquist JE; Williams PE; Lacy WW; Cherrington AD
    J Clin Invest; 1978 Aug; 62(2):487-91. PubMed ID: 670404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.
    Taborsky GJ; Ensinck JW
    J Clin Invest; 1984 Jan; 73(1):216-23. PubMed ID: 6140271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine suppresses plasma catecholamine responses to laparotomy but not to 2-deoxyglucose.
    Taborsky GJ; Halter JB; Porte D
    Am J Physiol; 1982 May; 242(5):E317-22. PubMed ID: 7081432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs.
    Wasserman DH; Lickley HL; Vranic M
    J Clin Invest; 1984 Oct; 74(4):1404-13. PubMed ID: 6148356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of morphine on glucose homeostasis in the conscious dog.
    Radosevich PM; Williams PE; Lacy DB; McRae JR; Steiner KE; Cherrington AD; Lacy WW; Abumrad NN
    J Clin Invest; 1984 Oct; 74(4):1473-80. PubMed ID: 6148357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.